543 related articles for article (PubMed ID: 19042970)
1. The DNA cleavage reaction of topoisomerase II: wolf in sheep's clothing.
Deweese JE; Osheroff N
Nucleic Acids Res; 2009 Feb; 37(3):738-48. PubMed ID: 19042970
[TBL] [Abstract][Full Text] [Related]
2. Stabilization of eukaryotic topoisomerase II-DNA cleavage complexes.
Wilstermann AM; Osheroff N
Curr Top Med Chem; 2003; 3(3):321-38. PubMed ID: 12570766
[TBL] [Abstract][Full Text] [Related]
3. Etoposide, topoisomerase II and cancer.
Baldwin EL; Osheroff N
Curr Med Chem Anticancer Agents; 2005 Jul; 5(4):363-72. PubMed ID: 16101488
[TBL] [Abstract][Full Text] [Related]
4. Topoisomerase II as a target for anticancer drugs: when enzymes stop being nice.
Fortune JM; Osheroff N
Prog Nucleic Acid Res Mol Biol; 2000; 64():221-53. PubMed ID: 10697411
[TBL] [Abstract][Full Text] [Related]
5. DNA topoisomerase II, genotoxicity, and cancer.
McClendon AK; Osheroff N
Mutat Res; 2007 Oct; 623(1-2):83-97. PubMed ID: 17681352
[TBL] [Abstract][Full Text] [Related]
6. Topoisomerase II Poisons: Converting Essential Enzymes into Molecular Scissors.
Vann KR; Oviatt AA; Osheroff N
Biochemistry; 2021 Jun; 60(21):1630-1641. PubMed ID: 34008964
[TBL] [Abstract][Full Text] [Related]
7. Exocyclic DNA lesions stimulate DNA cleavage mediated by human topoisomerase II alpha in vitro and in cultured cells.
Vélez-Cruz R; Riggins JN; Daniels JS; Cai H; Guengerich FP; Marnett LJ; Osheroff N
Biochemistry; 2005 Mar; 44(10):3972-81. PubMed ID: 15751973
[TBL] [Abstract][Full Text] [Related]
8. The use of divalent metal ions by type II topoisomerases.
Deweese JE; Osheroff N
Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of action of eukaryotic topoisomerase II and drugs targeted to the enzyme.
Burden DA; Osheroff N
Biochim Biophys Acta; 1998 Oct; 1400(1-3):139-54. PubMed ID: 9748545
[TBL] [Abstract][Full Text] [Related]
10. Cleavage of plasmid DNA by eukaryotic topoisomerase II.
Bandele OJ; Osheroff N
Methods Mol Biol; 2009; 582():39-47. PubMed ID: 19763940
[TBL] [Abstract][Full Text] [Related]
11. Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences.
Infante Lara L; Fenner S; Ratcliffe S; Isidro-Llobet A; Hann M; Bax B; Osheroff N
Nucleic Acids Res; 2018 Mar; 46(5):2218-2233. PubMed ID: 29447373
[TBL] [Abstract][Full Text] [Related]
12. 1,2-Naphthoquinone as a Poison of Human Type II Topoisomerases.
Collins JA; Osheroff N
Chem Res Toxicol; 2021 Apr; 34(4):1082-1090. PubMed ID: 33760604
[TBL] [Abstract][Full Text] [Related]
13. Topoisomerases as anticancer targets.
Delgado JL; Hsieh CM; Chan NL; Hiasa H
Biochem J; 2018 Jan; 475(2):373-398. PubMed ID: 29363591
[TBL] [Abstract][Full Text] [Related]
14. Effects of topoisomerase II-targeted drugs on enzyme-mediated DNA cleavage and ATP hydrolysis: evidence for distinct drug interaction domains on topoisomerase II.
Robinson MJ; Corbett AH; Osheroff N
Biochemistry; 1993 Apr; 32(14):3638-43. PubMed ID: 8385484
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugs.
Salerno S; Da Settimo F; Taliani S; Simorini F; La Motta C; Fornaciari G; Marini AM
Curr Med Chem; 2010; 17(35):4270-90. PubMed ID: 20939813
[TBL] [Abstract][Full Text] [Related]
16. Insight into Mechanism of Action of Anticancer Benzazoles.
Ozturk O; Aki-Yalcin E; Yalcin I; Grifitth R
Curr Top Med Chem; 2020; 20(23):2056-2069. PubMed ID: 32814529
[TBL] [Abstract][Full Text] [Related]
17. Coordinating the two protomer active sites of human topoisomerase IIalpha: nicks as topoisomerase II poisons.
Deweese JE; Osheroff N
Biochemistry; 2009 Feb; 48(7):1439-41. PubMed ID: 19166355
[TBL] [Abstract][Full Text] [Related]
18. Yeast recombination pathways triggered by topoisomerase II-mediated DNA breaks.
Sabourin M; Nitiss JL; Nitiss KC; Tatebayashi K; Ikeda H; Osheroff N
Nucleic Acids Res; 2003 Aug; 31(15):4373-84. PubMed ID: 12888496
[TBL] [Abstract][Full Text] [Related]
19. Covalent attachment of ethidium to DNA results in enhanced topoisomerase II-mediated DNA cleavage.
Marx G; Zhou H; Graves DE; Osheroff N
Biochemistry; 1997 Dec; 36(50):15884-91. PubMed ID: 9398321
[TBL] [Abstract][Full Text] [Related]
20. Mutation of cysteine residue 455 to alanine in human topoisomerase IIalpha confers hypersensitivity to quinones: enhancing DNA scission by closing the N-terminal protein gate.
Bender RP; Osheroff N
Chem Res Toxicol; 2007 Jun; 20(6):975-81. PubMed ID: 17516663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
